Aarkstore - Myungmoon pharmaceutical Co.,Ltd. - Product Pipeline Review - 2014

1
Myungmoon pharmaceutical Co.,Ltd. - Product
Pipeline Review - 2014
Category Pharmaceuticals Healthcare

• Browse Complete Report -
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/63686/myungmoon-pharmaceutical-coltd-product-pip
  eline-review

2
Myungmoon pharmaceutical Co.,Ltd. - Product
Pipeline Review - 2014
3
Summary

• Global Markets Directs, Myungmoon
  pharmaceutical Co.,Ltd. - Product Pipeline Review
  - 2014, provides an overview of the Myungmoon
  pharmaceutical Co.,Ltd.s pharmaceutical research
  and development focus.This report provides
  comprehensive information on the current
  therapeutic developmental pipeline of Myungmoon
  pharmaceutical Co.,Ltd.s, complete with
  comparative analysis at various stages,
  therapeutics assessment by drug target, mechanism
  of action (MoA), route of administration (RoA)
  and molecule type. It also reviews latest
  updates, and featured news and press releases,
  along with special features on late-stage and
  discontinued projects. Myungmoon pharmaceutical
  Co.,Ltd. - Product Pipeline Review - 2014"report
  features investigational drugs from across globe
  covering over 20 therapy areas and nearly 3,000
  indications. The report is built using data and
  information sourced from Global Markets Directs
  proprietary databases, Company/University
  websites, SEC filings, investor presentations and
  featured press releases from company/university
  sites and industry-specific third party sources,
  put together by Global Markets Directs team.

4
Summary

• Drug profiles/records featured in the report
  undergoes periodic updation following a stringent
  set of processes that ensures that all the
  profiles are updated with the latest set of
  information. Additionally, processes including
  live news deals tracking, browser based
  alert-box and clinical trials registries tracking
  ensure that the most recent developments are
  captured on a real time basis.  The report
  enhances decision making capabilities and help to
  create effective counter strategies to gain
  competitive advantage. It strengthens RD
  pipelines by identifying new targets and MOAs to
  produce first-in-class and best-in-class
  products.  Note Certain sections in the
  report may be removed or altered based on the
  availability and relevance of data for the
  indicated disease. 

5
Scope

• - The report provides brief overview of Myungmoon
  pharmaceutical Co.,Ltd. including business
  description, key information and facts, and its
  locations and subsidiaries - The report reviews
  current pipeline of Myungmoon pharmaceutical
  Co.,Ltd.s human therapeutic division and enlists
  all their major and minor projects - The report
  features product description and descriptive
  mechanism of action for key pipeline products
  along with the products developmental history
  and major milestones  - Special feature on
  out-licensed and partnered product portfolio -
  The report summarizes all the dormant and
  discontinued pipeline projects - Latest company
  statement  - Latest news and deals relating to
  the Myungmoon pharmaceutical Co.,Ltd.s pipeline
  products

6
Reasons to buy

• - Evaluate Myungmoon pharmaceutical Co.,Ltd.s
  strategic position with total access to detailed
  information on its product pipeline - Assess the
  growth potential of Myungmoon pharmaceutical
  Co.,Ltd. in its therapy areas of focus -
  Identify new drug targets and therapeutic classes
  in the Myungmoon pharmaceutical Co.,Ltd.s RD
  portfolio and develop key strategic initiatives
  to reinforce pipeline in those areas - Exploit
  in-licensing opportunities by identifying windows
  of opportunity to fill portfolio gaps - Develop
  strategic initiatives by understanding the focus
  areas of Myungmoon pharmaceutical Co.,Ltd. and
  exploit collaboration and partnership
  opportunities - Identify emerging players with
  potentially strong product portfolio and create
  effective counter-strategies to gain competitive
  advantage - Plan mergers and acquisitions
  effectively by identifying the most promising
  pipeline of Myungmoon pharmaceutical Co.,Ltd. -
  Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and scope   

7
Table of Content
List of Tables 3List of Figures 3Myungmoon
pharmaceutical Co.,Ltd. Snapshot 4Myungmoon
pharmaceutical Co., Ltd. Overview 4Key
Information 4Key Facts 4Myungmoon
pharmaceutical Co., Ltd. - Research and
Development Overview 5Key Therapeutic Areas
5Myungmoon pharmaceutical Co., Ltd. - Pipeline
Review 7Pipeline Products by Stage of
Development 7Pipeline Products - Monotherapy
8Myungmoon pharmaceutical Co.,Ltd. - Pipeline
Products Glance 9Myungmoon pharmaceutical
Co.,Ltd. - Early Stage Pipeline Products
9Discovery Products/Combination Treatment
Modalities 9
8
Table of Content
Myungmoon pharmaceutical Co.,Ltd. - Drug Profiles
10MM-A01-01 10Product Description 10Mechanism
of Action 10RD Progress 10MM-P01-01 11Product
Description 11Mechanism of Action 11RD
Progress 11MM-P01-02 12Product Description
12Mechanism of Action 12RD Progress
12MM-P02-01 13Product Description 13Mechanism
of Action 13RD Progress 13
9
List Of Tables

• Myungmoon pharmaceutical Co.,Ltd., Key
  Information 4Myungmoon pharmaceutical Co.,Ltd.,
  Key Facts 4Myungmoon pharmaceutical Co.,Ltd. -
  Pipeline by Indication, 2014 6Myungmoon
  pharmaceutical Co.,Ltd. - Pipeline by Stage of
  Development, 2014 7Myungmoon pharmaceutical
  Co.,Ltd. - Monotherapy Products in Pipeline, 2014
  8Myungmoon pharmaceutical Co.,Ltd. - Discovery,
  2014 9Myungmoon pharmaceutical Co.,Ltd. -
  Pipeline by Target, 2014 14Myungmoon
  pharmaceutical Co.,Ltd. - Pipeline by Molecule
  Type, 2014 15Myungmoon pharmaceutical Co.,Ltd. -
  Pipeline Products by Mechanism of Action, 2014
  16Myungmoon pharmaceutical Co.,Ltd., Other
  Locations 17   

10
List of Figures

• Myungmoon pharmaceutical Co.,Ltd. - Pipeline by
  Top 10 Indication, 2014 6

11
Related Reports

• Global Neurosurgery Market 2015-2019
• Active Pharmaceutical Ingredients (API) Market in
  India 2015-2019
• BrainStorm Cell Therapeutics Inc. (BCLI) -
  Financial and Strategic SWOT Analysis Review
• Ampio Pharmaceuticals, Inc. (AMPE) - Financial
  and Strategic SWOT Analysis Review
• MiMedx Group, Inc (MDXG) - Financial and
  Strategic SWOT Analysis Review

12
Related Reports

• Threshold Pharmaceuticals, Inc. (THLD) -
  Financial and Strategic SWOT Analysis Review
• MEI Pharma, Inc. (MEIP) - Financial and Strategic
  SWOT Analysis Review
• Titan Pharmaceuticals, Inc. (TTNP) - Financial
  and Strategic SWOT Analysis Review
• RedHill Biopharma Ltd. (RDHL) - Financial and
  Strategic SWOT Analysis Review
• Pharmaceuticals Healthcare Market Research
  Reports

13

• Myungmoon pharmaceutical Co.,Ltd. - Product
  Pipeline Review - 2014 Published Oct 2014 19
  Pages
• Myungmoon pharmaceutical Co.,Ltd. - Product
  Pipeline Review - 2014report features
  investigational drugs from across globe covering
  over 20 therapy areas and nearly 3,000
  indications.
  Price

Format Price
PDF 1500
Site Licence 3000
Enterprise Wide Licence 4500
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news